Michael A. Foley

3.9k total citations · 1 hit paper
32 papers, 1.8k citations indexed

About

Michael A. Foley is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael A. Foley has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Michael A. Foley's work include Chemical Synthesis and Analysis (8 papers), Peptidase Inhibition and Analysis (4 papers) and Coordination Chemistry and Organometallics (4 papers). Michael A. Foley is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Peptidase Inhibition and Analysis (4 papers) and Coordination Chemistry and Organometallics (4 papers). Michael A. Foley collaborates with scholars based in United States, Sweden and Germany. Michael A. Foley's co-authors include Stuart L. Schreiber, Paul A. Baron, Andrew Maynard, Vincent Castranova, Anna A. Shvedova, Elena R. Kisin, Matthew D. Shair, Daniel L. Comins, Derek S. Tan and Jack D. Brown and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Biochemistry.

In The Last Decade

Michael A. Foley

32 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exposure to Carbon Nanotube Material: Aerosol Release During the Handling of Unrefined Single-Walled Carbon Nanotube Material

2004 549 citations Andrew Maynard, Paul A. Baron et al. Journal of Toxicology and Environmental Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Foley United States	19	830	718	481	235	234	32	1.8k
Virginie Lhiaubet‐Vallet Spain	23	838 1.0×	533 0.7×	578 1.2×	85 0.4×	176 0.8×	86	2.1k
Phanourios Tamamis United States	24	885 1.1×	235 0.3×	243 0.5×	164 0.7×	97 0.4×	74	1.8k
Wen‐Shan Li Taiwan	28	817 1.0×	634 0.9×	419 0.9×	49 0.2×	151 0.6×	81	2.2k
Fang Wei China	29	572 0.7×	1.5k 2.1×	316 0.7×	159 0.7×	71 0.3×	97	2.6k
Herbert E. Klei United States	21	687 0.8×	257 0.4×	262 0.5×	54 0.2×	193 0.8×	54	1.8k
Xiaoxing Wu China	26	547 0.7×	834 1.2×	201 0.4×	90 0.4×	115 0.5×	71	2.2k
Peter O’Neill United Kingdom	21	343 0.4×	356 0.5×	148 0.3×	105 0.4×	86 0.4×	50	1.4k
Sylvie Sauvaigo France	25	1.2k 1.5×	153 0.2×	310 0.6×	276 1.2×	118 0.5×	54	2.2k
Robert H. Sik United States	20	486 0.6×	360 0.5×	218 0.5×	84 0.4×	158 0.7×	43	1.6k
Fengbo Wu China	27	887 1.1×	277 0.4×	128 0.3×	25 0.1×	232 1.0×	66	1.8k

Countries citing papers authored by Michael A. Foley

Since Specialization

Citations

This map shows the geographic impact of Michael A. Foley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Foley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Foley more than expected).

Fields of papers citing papers by Michael A. Foley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Foley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Foley. The network helps show where Michael A. Foley may publish in the future.

Co-authorship network of co-authors of Michael A. Foley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Foley. A scholar is included among the top collaborators of Michael A. Foley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Foley. Michael A. Foley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Rui, Daisuke Tomita, Yusuke Sasaki, et al.. (2022). A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors. ACS Medicinal Chemistry Letters. 13(3). 377–387. 4 indexed citations

Ginn, John D., Xiuju Jiang, Mayako Michino, et al.. (2021). Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions. ACS Infectious Diseases. 7(2). 435–444. 5 indexed citations

Fushimi, Makoto, Melanie Balbach, Navpreet Kaur, et al.. (2021). Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10). ACS Medicinal Chemistry Letters. 12(8). 1283–1287. 18 indexed citations

Nagiec, M. Marek, Jeremy R. Duvall, Adam Skepner, et al.. (2018). Novel tricyclic glycal-basedTRIB1inducers that reprogram LDL metabolism in hepatic cells. MedChemComm. 9(11). 1831–1842. 5 indexed citations

Duvall, Jeremy R., Leanne L. Bedard, Adel M. Naylor-Olsen, et al.. (2017). Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile. ACS Infectious Diseases. 3(5). 349–359. 16 indexed citations

Over, Björn, Pär Matsson, Christian Tyrchan, et al.. (2016). Structural and conformational determinants of macrocycle cell permeability. Nature Chemical Biology. 12(12). 1065–1074. 160 indexed citations

Duvall, Jeremy R., Lynn VerPlank, Barbara Ludeke, et al.. (2016). Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen. Antiviral Research. 131. 19–25. 11 indexed citations

Nagiec, M. Marek, Adam Skepner, Joseph Negri, et al.. (2015). Modulators of Hepatic Lipoprotein Metabolism Identified in a Search for Small-Molecule Inducers of Tribbles Pseudokinase 1 Expression. PLoS ONE. 10(3). e0120295–e0120295. 28 indexed citations

Lukens, Amanda K., Richard W. Heidebrecht, Carol A. Mulrooney, et al.. (2014). Diversity-Oriented Synthesis Probe TargetsPlasmodium falciparumCytochrome b Ubiquinone Reduction Site and Synergizes With Oxidation Site Inhibitors. The Journal of Infectious Diseases. 211(7). 1097–1103. 19 indexed citations

10.

Dandapani, Sivaraman, Andrew Germain, Jean‐Charles Marié, et al.. (2013). Diversity-Oriented Synthesis Yields a New Drug Lead for Treatment of Chagas Disease. ACS Medicinal Chemistry Letters. 5(2). 149–153. 35 indexed citations

11.

Maynard, Andrew, Paul A. Baron, Michael A. Foley, et al.. (2004). Exposure to Carbon Nanotube Material: Aerosol Release During the Handling of Unrefined Single-Walled Carbon Nanotube Material. Journal of Toxicology and Environmental Health. 67(1). 87–107. 549 indexed citations breakdown →

12.

Kurosu, Michio, James R. Porter, & Michael A. Foley. (2003). An efficient synthesis of indane-derived bis(oxazoline) and its application to hetero Diels–Alder reactions on polymer support. Tetrahedron Letters. 45(1). 145–148. 23 indexed citations

13.

Clemons, Paul A., et al.. (2002). Synthesis of Calcineurin-Resistant Derivatives of FK506 and Selection of Compensatory Receptors. Chemistry & Biology. 9(1). 49–61. 34 indexed citations

14.

Blackwell, Helen E., et al.. (2001). A one-bead, one-stock solution approach to chemical genetics: part 1. Chemistry & Biology. 8(12). 1167–1182. 99 indexed citations

15.

Clemons, Paul A., Angela N. Koehler, Bridget K. Wagner, et al.. (2001). A one-bead, one-stock solution approach to chemical genetics: part 2. Chemistry & Biology. 8(12). 1183–1195. 88 indexed citations

16.

Tan, Derek S., Michael A. Foley, Brent R. Stockwell, Matthew D. Shair, & Stuart L. Schreiber. (1999). Synthesis and Preliminary Evaluation of a Library of Polycyclic Small Molecules for Use in Chemical Genetic Assays. Journal of the American Chemical Society. 121(39). 9073–9087. 93 indexed citations

17.

Foley, Michael A., David H. Drewry, Craig D. Wagner, et al.. (1996). Rapid synthesis of novel dipeptide inhibitors of human collagenase and gelatinase using solid phase chemistry. Bioorganic & Medicinal Chemistry Letters. 6(16). 1905–1910. 15 indexed citations

18.

Brown, Frank K., Peter J. Brown, D. Mark Bickett, et al.. (1994). Matrix Metalloproteinase Inhibitors Containing a [(Carboxyalkyl)amino]zinc Ligand: Modification of the P1 and P2' Residues. Journal of Medicinal Chemistry. 37(5). 674–688. 38 indexed citations

19.

Comins, Daniel L., et al.. (1994). Regio- and Stereoselective Addition of Nucleophiles to 1-Phenoxycarbonyl-2,3-dihydropyridinium Salts. Heterocycles. 37(2). 1121–1121. 28 indexed citations

20.

Poindexter, Graham S., et al.. (1993). Metalation of Hantzsch esters and mixed amide esters: a general route to C-2 functionalized 1,4-dihydropyridines. The Journal of Organic Chemistry. 58(15). 3811–3820. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact